You are here: Industry Insights > Biogen

News List

Fujifilm grabs Biogen biologics plant in Europe to bolster its CDMO business fiercepharma
March 13, 2019
Biogen will open brand-new biologics facilities in Switzerland and has decided it no longer needs its older operations in Denmark.
Biogen acquisition boosts its ophthalmology pipeline cphi-online
March 07, 2019
Nightstar Therapeutics has two potentially first-in-class mid- to late-stage clinical assets as well as preclinical programs.
Biogen to Acquire Nightstar Therapeutics americanpharmaceuticalreview
March 06, 2019
Biogen has entered into an agreement to acquire Nightstar Therapeutics, a clinical-stage gene therapy company based in London, United Kingdom, which is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders.
Biogen to buy gene therapy firm Nightstar Therapeutics for $800m pharmaceutical-technology
March 05, 2019
US-based biotechnology company Biogen has signed an agreement to acquire UK-based gene therapy firm Nightstar Therapeutics for a cash consideration of $800m.
Alkermes, Biogen Announce FDA Acceptance of Diroximel Fumarate NDA americanpharmaceuticalreview
February 27, 2019
Alkermes and Biogen announced the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for diroximel fumarate (BIIB098) .....
Biogen faces multibillion-dollar Tecfidera loss if Mylan wins latest patent threat fiercepharma
February 24, 2019
Cash cow Tecfidera has been pumping out blockbuster sales as Biogen plows ahead with pricey Alzheimer's trials and scouts for new pipeline assets. But what if those sales took a big hit early next year, instead of eight years later?
Biogen signs two deals to address neurological disorders pharmaceutical-technology
January 08, 2019
Biogen has signed a strategic collaboration with US-based drug maker C4 Therapeutics for the discovery and development of new therapies to treat neurological diseases, including Alzheimer’s disease.
Pair of deals boosts Biogen’s early-stage CNS pipeline pharmaphorum
January 08, 2019
Biogen has signed a brace of collaborations to expand its central nervous system (CNS) pipeline, adding new candidates for Alzheimer’s, multiple sclerosis and other neurological diseases.
Biogen signs two deals to address neurological disorders pharmaceutical-technology
January 08, 2019
Biogen has signed a strategic collaboration with US-based drug maker C4 Therapeutics for the discovery and development of new therapies to treat neurological diseases, including Alzheimer’s disease.....
Biogen bails on AGTC after ocular gene therapy flunks trial fiercebiotech
December 26, 2018
Applied Genetic Technologies’ $1 billion-plus gene therapy pact with Biogen has been torn up after their lead candidate failed a phase 1/2 trial.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page